Papers/PMID:29509641
Caffeine, CYP1A2 Genotype, and Endurance Performance in Athletes.
Medicine and science in sports and exercise2018The record
1 finding drawn from this paper, on 1 compound across 1 endpoint.
What it reported
How to read these marksWhat moved
1 finding
caffeine — decreases time-trial completion time
PreliminaryGrade D, Preliminary. Non-human or in vitro only.Findingreplicated ×2“Overall, 4 mg·kg caffeine decreased cycling time by 3% (mean ± SEM) versus placebo (17.6 ± 0.1 vs 18.1 ± 0.1 min, P = 0.01).”
Quoted verbatim from Caffeine, CYP1A2 Genotype, and Endurance Performance in Athletes.. - Study
- crossover
- Participants
- 101
- Dose
- 4 mg/kg caffeine, single dose
- Population
- competitive male athletes, whole cohort pooled across CYP1A2 genotypes, 10-km cycling time trial
Caffeine, CYP1A2 Genotype, and Endurance Performance in Athletes.2018PMID:29509641